Recent HIV/AIDS News

April 30, 2013: U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for HIV “The U.S. Preventive Services Task Force (Task Force) today released its final recommendation statement on screening for HIV. The Task Force recommends that clinicians screen all people aged 15 to 65, as well as younger adolescents and older adults who are at an increased risk for HIV infection.” Read the AIDS.gov blog post.   April 25, 2013: Prezista (Darunavir) Labeling Changes “On April 24, 2013, FDA approved revisions to the Prezista (darunavir) tablet and oral suspension label to update labeling with 48 week data from study TMC114-C228 for HIV-1 treatment experienced pediatric patients three to less than 6 years of age.”  Read the FDA announcement. April 25, 2013: NIH Discontinues Immunizations in HIV Vaccine Study “The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will stop administering injections in its HVTN 505 clinical trial of an investigational HIV vaccine regimen because an independent data and safety monitoring board (DSMB) found during a scheduled interim review that the vaccine regimen did not prevent HIV infection nor reduce viral load (the amount of HIV in the blood) among vaccine recipients who became infected with HIV.” Read the NIAID press release.   A...